These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 9889213)

  • 61. Evaluation of the Cobas AmpliPrep/Cobas Amplicor HIV-1 Monitor Ultrasensitive Test: comparison with the Cobas Amplicor HIV-1 Monitor test (manual specimen preparation).
    Berger A; Scherzed L; Stürmer M; Preiser W; Doerr HW; Rabenau HF
    J Clin Virol; 2002 Dec; 25 Suppl 3():S103-7. PubMed ID: 12467784
    [TBL] [Abstract][Full Text] [Related]  

  • 62. New design, development, and optimization of an in-house quantitative TaqMan Real-time PCR assay for HIV-1 viral load measurement.
    Noorbazargan H; Nadji SA; Samiee SM; Paryan M; Mohammadi-Yeganeh S
    HIV Clin Trials; 2018 Apr; 19(2):61-68. PubMed ID: 29473487
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A RealTime HIV-1 viral load assay for automated quantitation of HIV-1 RNA in genetically diverse group M subtypes A-H, group O and group N samples.
    Tang N; Huang S; Salituro J; Mak WB; Cloherty G; Johanson J; Li YH; Schneider G; Robinson J; Hackett J; Swanson P; Abravaya K
    J Virol Methods; 2007 Dec; 146(1-2):236-45. PubMed ID: 17707519
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Evaluation of two commercial procedures for quantification of human immunodeficiency virus type 1 RNA with respect to HIV-1 viral subtype and antiviral treatment.
    Schmid I; Arrer E; Hawranek T; Patsch W
    Clin Lab; 2000; 46(7-8):355-60. PubMed ID: 10934582
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Intracellular concentration of protease inhibitors in HIV-1-infected patients: correlation with MDR-1 gene expression and low dose of ritonavir.
    Chaillou S; Durant J; Garraffo R; Georgenthum E; Roptin C; Clevenbergh P; Dunais B; Mondain V; Roger PM; Dellamonica P
    HIV Clin Trials; 2002; 3(6):493-501. PubMed ID: 12501133
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A sensitive in-house RT-PCR genotyping system for combined detection of plasma HIV-1 and assessment of drug resistance.
    Steegen K; Demecheleer E; De Cabooter N; Nges D; Temmerman M; Ndumbe P; Mandaliya K; Plum J; Verhofstede C
    J Virol Methods; 2006 May; 133(2):137-45. PubMed ID: 16375980
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A sensitive PCR assay system for the quantitation of viral genome equivalents: human immunodeficiency virus type 1 (HIV-1) and hepatitis B virus (HBV).
    Hämmerle T; Himmelspach M; Dorner F; Falkner FG
    Arch Virol; 1997; 142(7):1297-306. PubMed ID: 9267444
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Intra-assay performance characteristics of five assays for quantification of human immunodeficiency virus type 1 RNA in plasma.
    Lin HJ; Pedneault L; Hollinger FB
    J Clin Microbiol; 1998 Mar; 36(3):835-9. PubMed ID: 9508327
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Long-term suppression of plasma viremia with highly active antiretroviral therapy despite virus evolution and very limited selection of drug-resistant genotypes.
    Pariente N; Pernas M; de la Rosa R; Gómez-Mariano G; Fernández G; Rubio A; López M; Benito JM; López-Galíndez C; Leal M; Domingo E; Martinez MA; Mas A
    J Med Virol; 2004 Jul; 73(3):350-61. PubMed ID: 15170628
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Virological efficacy and plasma drug concentrations of nelfinavir plus saquinavir as salvage therapy in HIV-infected patients refractory to standard triple therapy.
    Reiser M; Salzberger B; Stiepel A; Hoetelmans R; Diehl V; Fätkenheuer G
    Eur J Med Res; 1999 Feb; 4(2):54-8. PubMed ID: 10066640
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Quantification of integrated and total HIV-1 DNA after long-term highly active antiretroviral therapy in HIV-1-infected patients.
    Ibáñez A; Puig T; Elias J; Clotet B; Ruiz L; Martínez MA
    AIDS; 1999 Jun; 13(9):1045-9. PubMed ID: 10397534
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Quantitation of human immunodeficiency virus type 1 (HIV-1) RNA in cell-free cervicovaginal secretions: comparison of reverse transcription-PCR amplification (AMPLICOR HIV-A MONITOR 1.5) with enhanced-sensitivity branched-DNA assay (Quantiplex 3.0).
    Si-Mohamed A; Andreoletti L; Colombet I; Carreno MP; Lopez G; Chatelier G; Kazatchkine MD; Belec L
    J Clin Microbiol; 2001 Jun; 39(6):2055-9. PubMed ID: 11376034
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Impact of treatment with human immunodeficiency virus (HIV) protease inhibitors on hepatitis C viremia in patients coinfected with HIV.
    Rutschmann OT; Negro F; Hirschel B; Hadengue A; Anwar D; Perrin LH
    J Infect Dis; 1998 Mar; 177(3):783-5. PubMed ID: 9498464
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparative evaluation of the Cobas Amplicor HIV-1 Monitor Ultrasensitive Test, the new Cobas AmpliPrep/Cobas Amplicor HIV-1 Monitor Ultrasensitive Test and the Versant HIV RNA 3.0 assays for quantitation of HIV-1 RNA in plasma samples.
    Berger A; Scherzed L; Stürmer M; Preiser W; Doerr HW; Rabenau HF
    J Clin Virol; 2005 May; 33(1):43-51. PubMed ID: 15797364
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Drug resistance at low viraemia in HIV-1-infected patients with antiretroviral combination therapy.
    Aleman S; Söderbärg K; Visco-Comandini U; Sitbon G; Sönnerborg A
    AIDS; 2002 May; 16(7):1039-44. PubMed ID: 11953470
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clinical performance of an in-house real-time RT-PCR assay using a fluorogenic LUX primer for quantitation of human immunodeficiency virus type-1 (HIV-1).
    Rekhviashvili N; Stevens W; Marinda E; Gonin R; Stevens G; McIntyre J; Wood R
    J Virol Methods; 2007 Dec; 146(1-2):14-21. PubMed ID: 17628709
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Duration and predictors of CD4 T-cell gains in patients who continue combination therapy despite detectable plasma viremia.
    Deeks SG; Barbour JD; Grant RM; Martin JN
    AIDS; 2002 Jan; 16(2):201-7. PubMed ID: 11807304
    [TBL] [Abstract][Full Text] [Related]  

  • 78. High rebound of plasma and cellular HIV load after discontinuation of triple combination therapy.
    Jubault V; Burgard M; Le Corfec E; Costagliola D; Rouzioux C; Viard JP
    AIDS; 1998 Dec; 12(17):2358-9. PubMed ID: 9863885
    [No Abstract]   [Full Text] [Related]  

  • 79. Quantitation of human immunodeficiency virus type 1 RNA in cell free seminal plasma: comparison of NASBA with Amplicor reverse transcription-PCR amplification and correlation with quantitative culture.
    Dyer JR; Gilliam BL; Eron JJ; Grosso L; Cohen MS; Fiscus SA
    J Virol Methods; 1996 Jul; 60(2):161-70. PubMed ID: 8844622
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Nucleoside analogs plus ritonavir in stable antiretroviral therapy-experienced HIV-infected children: a randomized controlled trial. Pediatric AIDS Clinical Trials Group 338 Study Team.
    Nachman SA; Stanley K; Yogev R; Pelton S; Wiznia A; Lee S; Mofenson L; Fiscus S; Rathore M; Jimenez E; Borkowsky W; Pitt J; Smith ME; Wells B; McIntosh K
    JAMA; 2000 Jan; 283(4):492-8. PubMed ID: 10659875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.